Nektar Therapeutics (0UNL)
Market Closed
26 Oct, 03:30 PM
$
37. 23
+0.12
+0.3258%
$
- Market Cap
- P/E Ratio
- Div Yield
364 Volume
-0.72 Eps
$ 37.11
Previous Close Want to track 0UNL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
0UNL Earnings Reports FAQ
What is the earnings per share (EPS) for 0UNL?
The current EPS is -0.72.
What is the company's earnings growth rate?
Nektar Therapeutics has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Nektar Therapeutics has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nektar Therapeutics are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0UNL at this time, as Nektar Therapeutics has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
